Aurinia Pharmaceuticals Inc. (AUPH) Financials

AUPH Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 724.0 million 156.4 million
Dec. 31, 2025 751.6 million 170.3 million
Sept. 30, 2025 527.5 million 161.8 million
June 30, 2025 502.6 million 167.3 million

AUPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 32.5 million -866000
Dec. 31, 2025 44.5 million 6.7 million
Sept. 30, 2025 44.4 million 5.9 million
June 30, 2025 44.1 million 5.4 million

AUPH Net Income

No data available :(

AUPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 378.8 million 50.5 million 68.6 million
Dec. 31, 2025 398.0 million 57.2 million 74.8 million
Sept. 30, 2025 351.8 million - 60.8 million
June 30, 2025 315.1 million - 81.8 million

AUPH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 137.6 million
Dec. 31, 2025 138.7 million
Sept. 30, 2025 136.0 million
June 30, 2025 143.2 million

AUPH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 39000 7.5 million 22.0 million 327000
Dec. 31, 2025 69764 10.9 million 29.3 million 1.8 million
Sept. 30, 2025 65000 8.4 million 26.2 million -
June 30, 2025 98000 7.4 million 26.0 million 848000

AUPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 77.7 million 6.5 million
Dec. 31, 2025 77.1 million 8.5 million
Sept. 30, 2025 73.5 million 8.5 million
June 30, 2025 70.0 million 7.1 million

AUPH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AUPH

Price: $16

52 week price:
7.29
16.88

Earnings Per Share: 2.16 USD

P/E Ratio: 7.07

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 2.2 million

Ebitda: -13.4 million

Market Capitalization: 2.0 billion

Links: